header
Image from OpenLibrary

Stability study of the therapeutic BCG- T using lyophilization technique and different stabilizing agents / Dalia Mohamed Sayed Ahmed ; Supervised Soad Aly Yehia , Aly Fahmy Mohamed , Ibrahim Elsayed Mohamed Hassan

By: Contributor(s): Material type: TextTextLanguage: English Publication details: Cairo : Dalia Mohamed Sayed Ahmed , 2014Description: 149 P. : photographs ; 25cmOther title:
  • دراسة ثبات مستحضر ال بى سى جى العلاجى باستخدام تقنية التجفيد و أنواع مختلفة من المثبتات [Added title page title]
Subject(s): Available additional physical forms:
  • Issued also as CD
Dissertation note: Thesis (M.Sc.) - Cairo University - Faculty of Pharmacy - Department of Pharmaceutics Summary: Bacillus calmette and guerin (BCG) has been commonly known as an anti tuberculosis vaccine since it was first introduced in paris by calmette and Guerin. Later it was discovered as an important immunotherapeutic agent for treatment of superficial bladder cancer. Being a standard care for many types of bladder cancer, it was one of the early cancer vaccines approved by the FDA. Only two internationally freeze dried BCG products are approved for bladder cancer treatment worldwide due to several restrictions in WHO guidelines. Other manufactures can only distribute their BCG products in their local markets as in case of the Egyptian immunotherapeutic liquid BCG- T. The increased demands of the product in Egypt are associated with the increased bladder cancer incidences. Therefore, development of freeze dried formula has become an urgent need to increase vaccine stability
Tags from this library: No tags from this library for this title. Log in to add tags.
Star ratings
    Average rating: 0.0 (0 votes)
Holdings
Item type Current library Home library Call number Copy number Status Date due Barcode
Thesis Thesis قاعة الرسائل الجامعية - الدور الاول المكتبة المركزبة الجديدة - جامعة القاهرة Cai01.08.08.M.Sc.2014.Da.S (Browse shelf(Opens below)) Not for loan 01010110064582000
CD - Rom CD - Rom مخـــزن الرســائل الجـــامعية - البدروم المكتبة المركزبة الجديدة - جامعة القاهرة Cai01.08.08.M.Sc.2014.Da.S (Browse shelf(Opens below)) 64582.CD Not for loan 01020110064582000

Thesis (M.Sc.) - Cairo University - Faculty of Pharmacy - Department of Pharmaceutics

Bacillus calmette and guerin (BCG) has been commonly known as an anti tuberculosis vaccine since it was first introduced in paris by calmette and Guerin. Later it was discovered as an important immunotherapeutic agent for treatment of superficial bladder cancer. Being a standard care for many types of bladder cancer, it was one of the early cancer vaccines approved by the FDA. Only two internationally freeze dried BCG products are approved for bladder cancer treatment worldwide due to several restrictions in WHO guidelines. Other manufactures can only distribute their BCG products in their local markets as in case of the Egyptian immunotherapeutic liquid BCG- T. The increased demands of the product in Egypt are associated with the increased bladder cancer incidences. Therefore, development of freeze dried formula has become an urgent need to increase vaccine stability

Issued also as CD

There are no comments on this title.

to post a comment.